Ferric citrate: a novel phosphate-binding agent

被引：0
|
作者：
Umanath, Kausik [1 ]
Niecestro, Robert
Lewis, Julia B. [2 ]
Dwyer, Jamie P. [2 ]
机构：
[1] Henry Ford Hosp, Div Nephrol & Hypertens, Detroit, MI 48202 USA
[2] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN USA
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2013年 / 8卷 / 01期
关键词：
CKD-MBD; ESRD; iron metabolism; metabolic acidosis; phosphate binder;
D O I：
10.1586/EEM.12.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ferric citrate (KRX-0502; Keryx Biopharmaceuticals, Inc., NY, USA) is a novel phosphate-binding agent presently in Phase III clinical development. Ferric citrate dissociates in the bowel lumen releasing the ferric ion to precipitate with dietary phosphorus, which is then excreted in the stool. Studies to date have shown the agent to be efficacious and safe with only mild gastrointestinal side effects. Absorption of either component of the agent (ferric iron or citrate) has the potential to be of benefit for patients with end-stage renal disease. An ongoing Phase III trial is confirming the safety and efficacy of ferric citrate as a phosphate binder in dialysis patients.
引用
收藏
页码：13 / 19
页数：7
相关论文
共 50 条
  • [21] Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis
    Bro, S
    Rasmussen, RA
    Handberg, J
    Olgaard, K
    Feldt-Rasmussen, B
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) : 257 - 262
  • [22] Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
    Ganz, Tomas
    Bino, Avi
    Salusky, Isidro B.
    DRUGS, 2019, 79 (09) : 957 - 968
  • [23] Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
    Karen Rascati
    Drugs in R&D, 2017, 17 : 487 - 488
  • [24] The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats
    Matsuo, Akira
    Iida, Akio
    Tanimoto, Minako
    Matsushita, Mutsuyoshi
    Miyamoto, Ken-ichi
    RENAL FAILURE, 2014, 36 (08) : 1291 - 1297
  • [25] Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis
    Umanath, Kausik
    Sika, Mohammed
    Niecestro, Robert
    Connelly, Carolyn
    Schulman, Gerald
    Koury, Mark J.
    Lewis, Julia B.
    Dwyer, Jamie P.
    HEMODIALYSIS INTERNATIONAL, 2013, 17 (01) : 67 - 74
  • [26] Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
    Lewis, Julia B.
    Sika, Mohammed
    Koury, Mark J.
    Chuang, Peale
    Schulman, Gerald
    Smith, Mark T.
    Whittier, Frederick C.
    Linfert, Douglas R.
    Galphin, Claude M.
    Athreya, Balaji P.
    Nossuli, A. Kaldun Kaldun
    Chang, Ingrid J.
    Blumenthal, Samuel S.
    Manley, John
    Zeig, Steven
    Kant, Kotagal S.
    Olivero, Juan Jose
    Greene, Tom
    Dwyer, Jamie P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (02): : 493 - 503
  • [27] Extended release nicotinic acid - a novel oral agent for phosphate control
    Sampathkumar, Krishnaswamy
    Selvam, Manickam
    Sooraj, Yesudas Santhakumari
    Gowthaman, Sankaran
    Ajeshkumar, Rajappan Nair Prabha
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (01) : 171 - 174
  • [28] Extended Release Nicotinic Acid – A Novel Oral Agent for Phosphate Control
    Krishnaswamy Sampathkumar
    Manickam Selvam
    Yesudas Santhakumari Sooraj
    Sankaran Gowthaman
    Rajappan Nair Prabha Ajeshkumar
    International Urology and Nephrology, 2006, 38 : 171 - 174
  • [29] The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial
    Van Buren, Peter N.
    Lewis, Julia B.
    Dwyer, Jamie P.
    Greene, Tom
    Middleton, John
    Sika, Mohammed
    Umanath, Kausik
    Abraham, Josephine D.
    Arfeen, Shahabul S.
    Bowline, Isai G.
    Chernin, Gil
    Fadem, Stephen Z.
    Goral, Simin
    Koury, Mark
    Sinsakul, Marvin V.
    Weiner, Daniel E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (03) : 479 - 488
  • [30] Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
    Rodby R.A.
    Umanath K.
    Niecestro R.
    Christopher Bond T.
    Sika M.
    Lewis J.
    Dwyer J.P.
    Drugs in R&D, 2015, 15 (3) : 271 - 279
12345